JW (Cayman) Therapeutics Co. Ltd. Financial Overview
JW (Cayman) Therapeutics Co. Ltd.'s market cap is currently HK$1.17B. The company's EPS TTM is HK$-0.6989135168; its P/E ratio is -1.71; JW (Cayman) Therapeutics Co. Ltd. is scheduled to report earnings on August 27, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
